Clinical Trial Update: Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of lubiprostone in pediatric patients 6 to <18 years with functional constipation completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Sucampo Pharma Americas, LLC | Conditions: Constipation - Functional | Phase 3 | Status: COMPLETED | Results posted: 2020-05-15